Liquidia LQDA
NASDAQ LQDA
$47.87 +3.47 (+7.82%)
At close: Nov 9, 2026 · 4:00 PM EST

Liquidia (LQDA) Return on Sales [ROS] (2020 - 2026)

Updated

Liquidia's Return on Sales [ROS] was 49.81% in Q2 2026, up 474.22 percentage points from -424.41% a year earlier and up 3.52 percentage points from the prior quarter.

Analysis

Liquidia (LQDA) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Liquidia's Return on Sales [ROS] was 37.39% through Jun 30, 2026, up 752.77 percentage points year-over-year; for FY2025, it came in at -32.45%, up 834.18 percentage points from FY2024.

  • Return on Sales [ROS] shows a five-year change of +7956.58 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was -866.63% in FY2024 (-447.01 pp), -419.62% in FY2023 (-176.32 pp), -243.30% in FY2022 (+19.65 pp) and -262.95% in FY2021 (+7726.08 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Sales [ROS] in data going back to Q4 2020.
  • Compared with a year earlier, Return on Sales [ROS] has increased for five straight quarters, with an average year-over-year change of +352.69 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q4 2021 (a gain of 1798.16 percentage points); the worst was Q1 2024 (a drop of 763.60 percentage points).
  • Per Business Quant data, LQDA's Return on Sales [ROS] in the three quarters before Q2 2026 was 46.29% (Q1 2026), 21.50% (Q4 2025) and 3.25% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 52.42%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 24.35%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 36.01%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 30.89%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 29.12%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 35.79%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 41.71%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 32.98%
10 Liquidia 4.27 Bn 3.41 Bn 160.13 Mn 49.81%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 49.81%
Mar 31, 2026 46.29%
Dec 31, 2025 21.50%
Sep 30, 2025 3.25%
Jun 30, 2025 -424.41%
Mar 31, 2025 -1,135.42%
Dec 31, 2024 -1,237.81%
Sep 30, 2024 -656.23%
Jun 30, 2024 -743.29%
Mar 31, 2024 -969.08%
Dec 31, 2023 -583.45%
Sep 30, 2023 -404.87%
Jun 30, 2023 -476.91%
Mar 31, 2023 -205.48%
Dec 31, 2022 -121.21%
Sep 30, 2022 -279.02%
Jun 30, 2022 -228.94%
Mar 31, 2022 -414.43%
Dec 31, 2021 -353.41%
Sep 30, 2021 -222.71%
API Access

Liquidia Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=LQDA&period=max&api_key=YOUR_API_KEY